Literature DB >> 2781291

Identification of monocyte chemotactic activity produced by malignant cells.

D T Graves1, Y L Jiang, M J Williamson, A J Valente.   

Abstract

Human malignant cells secrete low molecular size proteins that attract peripheral blood monocytes and may be responsible for the accumulation of tumor-associated macrophages observed in vivo. Similar chemotactic proteins are secreted by cultured vascular smooth muscle cells. The predominant monocyte chemoattractants produced by tumor cells of differing origin were demonstrated to be related to smooth muscle cell-derived chemotactic factor. Thus, a single class of chemotactic proteins is produced by different cell types, which suggests a common mechanism for the recruitment of monocytes and macrophages. These results are significant in view of the potential of macrophages to affect tumor growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781291     DOI: 10.1126/science.2781291

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  43 in total

1.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.

Authors:  B J Rollins; T Yoshimura; E J Leonard; J S Pober
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

2.  Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.

Authors:  B J Rollins; M E Sunday
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 3.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

4.  Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancer.

Authors:  J Kruse; W von Bernstorff; K Evert; N Albers; S Hadlich; S Hagemann; C Günther; N van Rooijen; C-D Heidecke; L I Partecke
Journal:  Int J Colorectal Dis       Date:  2013-05-09       Impact factor: 2.571

5.  Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.

Authors:  Y Nakano; T Kasahara; N Mukaida; Y C Ko; M Nakano; K Matsushima
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

Authors:  F Marra; A J Valente; M Pinzani; H E Abboud
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers.

Authors:  Y J Shyy; L L Wickham; J P Hagan; H J Hsieh; Y L Hu; S H Telian; A J Valente; K L Sung; S Chien
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Expression of monocyte chemoattractant protein 1 in human inflamed gingival tissues.

Authors:  X Yu; H N Antoniades; D T Graves
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence.

Authors:  A Trulson; S Nilsson; E Brekkan; P Venge
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

10.  Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.

Authors:  A E Koch; S L Kunkel; L A Harlow; B Johnson; H L Evanoff; G K Haines; M D Burdick; R M Pope; R M Strieter
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.